Terms: = Uterine cancer AND SERPINE1, PAI, PAI-1, PAI1, PLANH1 AND Staging
5 results:
1. Analysis of potential prognostic factors in 111 patients with ovarian cancer.
Hornung R; Urs E; Serenella E; Edward W; Ursula S; Urs H; Daniel F
Cancer Lett; 2004 Mar; 206(1):97-106. PubMed ID: 15019165
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
[TBL] [Abstract] [Full Text] [Related]
3. Plasminogen activator inhibitor type 2: potential prognostic factor for endometrial carcinomas.
Osmak M; Babić D; Abramić M; Milicić D; Vrhovec I; Skrk J
Neoplasma; 2001; 48(6):462-7. PubMed ID: 11949838
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-associated proteolytic factors uPA and pai-1 in endometrial carcinoma.
Köhler U; Hiller K; Martin R; Langanke D; Naumann G; Bilek K; Jänicke F; Schmitt M
Gynecol Oncol; 1997 Aug; 66(2):268-74. PubMed ID: 9264575
[TBL] [Abstract] [Full Text] [Related]
5. Chemotherapeutic approach to uterine papillary serous carcinoma.
Hamaguchi K; Komai K; Sakihama H; Okura N; Nagasue N; Nishida T; Yakushiji M
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):367-72. PubMed ID: 2129190
[TBL] [Abstract] [Full Text] [Related]
